Lack of appropriate formulations of medicines for children in the community
- PMID: 14971804
- DOI: 10.1080/08035250310006728
Lack of appropriate formulations of medicines for children in the community
Abstract
Aim: Appropriate formulations are essential in pharmacotherapy. This study surveyed the use of different formulations by children in the community, and examined the reported lack of appropriate formulations (oral solutions) in relation to the licensing status of drugs.
Methods: A cross-sectional study based on 68,019 pharmacy dispensing records was performed in The Netherlands. For each prescription the formulation was assessed, and all prescriptions were categorized: unlicensed (no product licence), off-label (licensed drugs used outside the licence terms) and authorized (licensed drugs used according to the licence). The types of formulation used were assessed in relation to age and licensing status.
Results: In all age groups, approximately half of all prescriptions were for oral drugs. The only major age-related trend was within oral drugs: younger children were more likely to be prescribed oral solutions. For authorized drugs the proportion of tablet/capsules exceeded oral solutions at the age of 7 y, whereas for off-label drugs this occurred at 3 y of age. For those medicines prepared by the pharmacy, tablets and capsules were more likely to be prescribed from the age of 9 y.
Conclusion: Many children in the community receive inappropriate oral formulations. Regulatory authorities and the pharmaceutical industry need to ensure that children have access to medicines with appropriate formulations.
Similar articles
-
Risk factors for unlicensed and off-label drug use in children outside the hospital.Pediatrics. 2003 Feb;111(2):291-5. doi: 10.1542/peds.111.2.291. Pediatrics. 2003. PMID: 12563053
-
Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.Eur J Clin Pharmacol. 2002 Jul;58(4):293-7. doi: 10.1007/s00228-002-0479-9. Epub 2002 Jun 15. Eur J Clin Pharmacol. 2002. PMID: 12136376
-
Unlicensed and off-label prescription of respiratory drugs to children.Eur Respir J. 2004 Feb;23(2):310-3. doi: 10.1183/09031936.04.00015404. Eur Respir J. 2004. PMID: 14979509
-
Availability of Oral Formulations Labeled for Use in Young Children in Serbia, Germany and the USA.Curr Pharm Des. 2015;21(39):5668-73. doi: 10.2174/1381612821666150901105925. Curr Pharm Des. 2015. PMID: 26323413 Review.
-
Unlicensed and off-label uses of medicines: definitions and clarification of terminology.Br J Clin Pharmacol. 2017 Dec;83(12):2615-2625. doi: 10.1111/bcp.13394. Epub 2017 Sep 26. Br J Clin Pharmacol. 2017. PMID: 28779556 Free PMC article. Review.
Cited by
-
When do children convert from liquid antiretroviral to solid formulations?Pharm World Sci. 2005 Oct;27(5):399-402. doi: 10.1007/s11096-005-7911-z. Pharm World Sci. 2005. PMID: 16341747
-
Three years of paediatric regulation in the European Union.Eur J Clin Pharmacol. 2011 Mar;67(3):245-52. doi: 10.1007/s00228-011-0997-4. Epub 2011 Feb 1. Eur J Clin Pharmacol. 2011. PMID: 21286912
-
Overcoming Solubility Challenges: Self-emulsifying Systems for Enhancing the Delivery of Poorly Water-Soluble Antiviral Drugs.Pharm Nanotechnol. 2025;13(1):117-132. doi: 10.2174/0122117385280541231130055458. Pharm Nanotechnol. 2025. PMID: 38192138 Review.
-
Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.J Child Adolesc Psychopharmacol. 2018 Dec;28(10):699-710. doi: 10.1089/cap.2018.0020. Epub 2018 Oct 11. J Child Adolesc Psychopharmacol. 2018. PMID: 30132686 Free PMC article. Clinical Trial.
-
Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport.Br J Clin Pharmacol. 2022 Oct;88(10):4285-4296. doi: 10.1111/bcp.14534. Epub 2020 Sep 15. Br J Clin Pharmacol. 2022. PMID: 32851677 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
